We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

11 hedge funds and large institutions have $40.8M invested in Sinovac Biotech, Ltd in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% less funds holding

Funds holding: 29 → 11 (-18)

65% less capital invested

Capital invested by funds: $118M → $40.8M (-$76.8M)

89% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 19

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
11
Holders Change
-18
Holders Change %
-62.07%
% of All Funds
0.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
–
Reduced
2
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$8K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$72.7M
2
State Street
State Street
Massachusetts
-$1.82M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.54M
4
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$259K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$179K
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Vivo Capital
California
$38.2M – – –
NAH
2
Neumann Advisory (HK)
Hong Kong
$2.04M – – –
YMRC
3
Yorktown Management & Research Company
Virginia
$485K – – –
FIM
4
Freedom Investment Management
Connecticut
$111K -$1.06K -165 -0.9%
IA
5
IFP Advisors
Florida
$8K +$8K +18 New
FGAM
6
Financial Gravity Asset Management
Texas
$796 – – –
O
7
OrbiMed
New York
– -$72.7M -2,839,500 Closed
Renaissance Technologies
8
Renaissance Technologies
New York
– -$1.54M -2,375,841 Closed
State Street
9
State Street
Massachusetts
– -$1.82M -281,640 Closed
Skandinaviska Enskilda Banken (SEB)
10
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$259K -40,000 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$179K -27,717 Closed
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
– -$106K -16,430 Closed
Northern Trust
13
Northern Trust
Illinois
– -$55K -13,787 Closed
UBS Group
14
UBS Group
Switzerland
– -$59K -9,095 Closed
Morgan Stanley
15
Morgan Stanley
New York
– -$26K -3,941 Closed
JP Morgan Chase
16
JP Morgan Chase
New York
– -$19K -3,000 Closed
Northwestern Mutual Wealth Management
17
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -102 Closed

SVA Hedge Fund Activity: Q1 2022 in Review

11 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q1 2022, worth a combined $40.8M — down 65% from $118M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of SVA and 2 opened new positions — a net loss of 17 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $8K. The largest seller was OrbiMed, exiting entirely with an estimated $72.7M sold.

  • 11 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q1 2022, down from 29 in Q4 2021.
  • Funds reported $40.8M of Sinovac Biotech, Ltd stock for Q1 2022, down 65% quarter-over-quarter.
  • 2 funds opened new Sinovac Biotech, Ltd positions in Q1 2022 and 19 closed out, a net change of -17 holders.
  • The largest Sinovac Biotech, Ltd buyer in Q1 2022 was IFP Advisors, an estimated $8K added.
  • The largest Sinovac Biotech, Ltd seller in Q1 2022 was OrbiMed, an estimated $72.7M sold.

Based on aggregated 13F filings for Q1 2022.